Skip to main content Skip to navigation

 

 

CLL Phenotyping with BD Rhapsody™ Targeted Panels and BD® AbSeq Assays

 

Chronic Lymphoid Leukemia (CLL), the most common form of leukemia in adults, is often characterised by progressive accumulation of incompetent lymphocytes in blood and bone marrow.

Read More
performance1

Computational Sorting With HyperFinder, FlowJo™ Software and BD FACSDiva™ Software

 

The use of machine learning tools like tSNE, UMAP, CITRUS and CellCNN for the analysis of flow cytometry data may result in the discovery of novel cell types with a distinct pattern of surface markers.

Read More
performance1

Intracellular Flow Cytometry Analysis Reveals the Involvement of Prostaglandin in the Expansion of Regulatory Hematopoietic Cells in Type 1 Diabetes

 

The transplant of Haematopoetic Stem and Progenitor cells (HSPC) has been employed in the treatment of haematological malignancies. However, studies have shown that HSPCs also possess immunoregulatory properties, making them potentially attractive alternatives to immunosuppressive drugs for the treatment of  autoimmune diseases.

Read More
performance1

Analysing Pediatric Immune Response to SARS-CoV -2 Using Flow Cytometry


The COVID-19 pandemic has impacted every country in the world. In adults, 10-20% of the patients develop severe or life-threatening disease. However, in children, most patients display only minor symptoms and so their contributions to spreading the SARS-CoV-2 virus is unclear. 

Read More
performance1

BD Joins Consortium to Accelerate Technology Development and Lower the Costs in Cell and Gene Therapy Manufacturing


Wouldn’t it be wonderful if we could reach a point in medical history where disease can be cured without drugs? 

Read More
performance1

AbSeq Protocol Using the Nano-Well Cartridge-Based Rhapsody Platform to Generate Protein and Transcript Expression Data on the Single-Cell Level


The BD™ AbSeq oligonucleotide-conjugated antibodies, when incorporated into a single-cell mRNA-sequencing experiment, can yield combined transcript and protein expression data.

Read More
performance1

Bifidobacteria-Mediated Immune System Imprinting Early In Life


There is mounting evidence to suggest that during the first 3 months of life, the infant gut microbiome is crucial for immune development. Specialised microbes in the infant gut that rely on breast milk for nutrients play a key role in immune-microbe interactions.

Read More
performance1

Single-Cell Genomic Approaches for Developing the Next Generation of Immunotherapies

 

In recent times, developments in genomics, proteomics and single-cell technologies, coupled with advances in allied areas like computing and antibody engineering have enabled significant progress in drug development.

Read More
performance1

High-Dimensional Flow Cytometry in COVID-19

 

The rapid spread of COVID-19 infections all over the world and the need to develop a vaccine has necessitated the understanding of the adaptive immune response to the SARS-CoV-2 virus. 

Read More
performance1

High-Parameter Flow Cytometry for Deep Immune Profiling of COVID-19 Patients

 

The SARS-CoV-2 virus infection presents a range of clinical manifestations, ranging from mild or no symptoms to moderate to severe respiratory illnesses, such as ARDS (acute respiratory-distress syndrome) and multiorgan failure, to death. The innate immune defense mounted by the body involves pattern recognition receptors (PAR), which activate an array of transcription factors through a signal transduction pathway, ultimately resulting in the secretion of different interferons and chemokines.

Read More
performance1

Immunotyping of Natural Killer (NK) Cells in COVID-19 Patients Using High-Parameter Flow Cytometry

SARS-CoV-2 infection elicits a spectrum of immune responses, activating both the innate and adaptive immune systems. Whether these immune responses are targeted and controlled or misdirected and uncontrolled could determine the outcome of the disease. Recent studies using deep immunoprofiling have indicated that the nature of immune responses can also determine the severity of the disease.

Read More
performance1